Compounds > arginine

arginine and Tachycardia, Ventricular

arginine has been researched along with Tachycardia, Ventricular in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (22.22)	18.2507
2000's	5 (55.56)	29.6817
2010's	1 (11.11)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
David, H; Hoang, JD; Salavatian, S; Swid, MA; Vaseghi, M; Yamaguchi, N	1
Aydin, HH; Hasdemir, C; Sahin, S; Wollnik, B	1
Bode-Böger, SM; Bukowska, A; Ghanem, A; Goette, A; Hammwöhner, M; Klein, HU; Lehmann, HI; Martens-Lobenhoffer, J; Röhl, FW	1
Chen, CY; Hsueh, CH; Lai, LP; Lin, JL; Lin, TK; Lin, YH; Weng, YC	1
Blom, NA; Gyorke, I; Gyorke, S; Kubalova, Z; Napolitano, C; Nori, A; Priori, SG; Santoro, M; Terentyev, D; Terentyeva, R; Valle, G; Vedamoorthyrao, S; Viatchenko-Karpinski, S; Volpe, P; Williams, SC	1
Aspelin, T; Björkman, JA; Eriksen, M; Ilebekk, A; Lyberg, T; Nordlander, M; Sevre, K	1
Baron, AD; Fei, L; Henry, DP; Zipes, DP	1
Aronovitz, MJ; Berul, CI; Christe, ME; Maguire, CT; Mendelsohn, ME; Seidman, CE; Seidman, JG	1
Chan, P; Chen, SA; Chen, YJ; Chiou, CW; Tsai, CF	1

Other Studies

9 other study(ies) available for arginine and Tachycardia, Ventricular

Article	Year
Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y. JCI insight, 2020, 06-04, Volume: 5, Issue:11 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arginine; Disease Models, Animal; Neuropeptide Y; Receptors, Neuropeptide Y; Sus scrofa; Sympathetic Nervous System; Tachycardia, Ventricular	2020
Catecholaminergic polymorphic ventricular tachycardia caused by a novel mutation in the cardiac ryanodine receptor. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2008, Oct-16, Volume: 8, Issue:5 Topics: Adrenergic beta-Antagonists; Arginine; Calcium Channel Blockers; Defibrillators, Implantable; Exercise; Glutamine; Humans; Male; Mutation, Missense; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Treatment Outcome; Young Adult	2008
Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Defibrillators, Implantable; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Risk Factors; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left	2011
A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia. International journal of cardiology, 2006, Apr-04, Volume: 108, Issue:2 Topics: Adolescent; Arginine; Exercise; Female; Glutamine; Humans; Mutation, Missense; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular	2006
Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circulation research, 2006, May-12, Volume: 98, Issue:9 Topics: Amino Acid Substitution; Animals; Arginine; Binding, Competitive; Calcium; Calsequestrin; Cardiac Pacing, Artificial; Catecholamines; Death, Sudden, Cardiac; Exercise; Female; Glutamine; Humans; Intracellular Membranes; Mutation; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Recombinant Proteins; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Syncope; Tachycardia, Ventricular	2006
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246. Journal of cardiovascular pharmacology and therapeutics, 2006, Volume: 11, Issue:3 Topics: Animals; Arginine; Benzazepines; Biomarkers; Blood Pressure; Body Temperature; Carbon Dioxide; Cardiac Output; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Female; Heart Rate; Hematocrit; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxygen; Potassium; Receptors, Neuropeptide Y; Swine; Tachycardia, Ventricular; Ventricular Fibrillation	2006
Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properti Circulation, 1997, Dec-02, Volume: 96, Issue:11 Topics: Animals; Arginine; Confounding Factors, Epidemiologic; Disease Models, Animal; Dogs; Electric Stimulation; Enzyme Inhibitors; Myocardial Contraction; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pericardium; Severity of Illness Index; Tachycardia, Ventricular	1997
Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 1998, Volume: 2, Issue:1 Topics: Animals; Arginine; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Case-Control Studies; Electrocardiography; Female; Glutamine; Heart Conduction System; Heart Rate; Heart Ventricles; Heterozygote; Male; Mice; Mice, Inbred Strains; Mutation, Missense; Myosin Heavy Chains; Phenotype; Refractory Period, Electrophysiological; Sex Factors; Sinoatrial Node; Tachycardia, Ventricular	1998
Effect of nitric oxide on strophanthidin-induced ventricular tachycardia. Pharmacology, 2001, Volume: 62, Issue:4 Topics: Animals; Arginine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guinea Pigs; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Strophanthidin; Tachycardia, Ventricular	2001